Combination therapy with targeted 4-1BB (CD137) agonists/anti-FAP binding domain and anti-CEA/anti-CD3 bispecific antibody
US-12565530-B2 · Mar 3, 2026 · US
This page is not indexed by search engines while we improve data quality.
Levitski Viktor patents
Levitski Viktor is listed as an inventor on 40 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Levitski Viktor |
| Total patents | 40 |
| First publication | Nov 24, 2016 |
| Latest publication | Mar 3, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Methods of treating cancer by administering tumor necrosis factor (TNF) family ligand trimer-containing antigen-binding molecules
US-12441812-B2 · Oct 14, 2025 · US
Bispecific antibodies specific for PD1 and TIM3
US-12391757-B2 · Aug 19, 2025 · US
Antigen binding molecules comprising a tnf family ligand trimer
US-2025101135-A1 · Mar 27, 2025 · US
Bispecific antibodies specific for OX40
US-12240911-B2 · Mar 4, 2025 · US
Antigen binding molecules comprising a trimeric TNF family ligand and encoding polynucleotides thereof
US-12202870-B2 · Jan 21, 2025 · US
Anti-pd1 antibodies and methods of use
US-2024294642-A1 · Sep 5, 2024 · US
Combination therapy with targeted 4-1bb (cd137) agonists
US-2023357397-A1 · Nov 9, 2023 · US
Anti-pd1 antibodies and methods of use
US-2023183349-A1 · Jun 15, 2023 · US
Anti-pd1 antibodies and methods of use
US-2023143310-A1 · May 11, 2023 · US
Recent patents
Latest publications not already listed above.
Antigen Binding Molecules comprising a TNF family ligand trimer and PD1 binding moiety
US-2023123178-A1 · Apr 20, 2023 · US
Antigen binding molecules comprising a trimeric tnf family ligand
US-2022267395-A1 · Aug 25, 2022 · US
Antigen binding molecules comprising a tnf family ligand trimer
US-2022259327-A1 · Aug 18, 2022 · US
Antigen binding molecules comprising a tnf family ligand trimer
US-2022259326-A1 · Aug 18, 2022 · US
Bispecific antibodies specific for pd1 and tim3
US-2022259314-A1 · Aug 18, 2022 · US
Methods of treating cancer by administering antigen-binding molecules comprising a TNF family ligand trimer
US-11306154-B2 · Apr 19, 2022 · US
Bispecific antibodies with tetravalency for a costimulatory tnf receptor
US-2022073646-A1 · Mar 10, 2022 · US
Antigen-binding molecules comprising a tumor necrosis factor (TNF) family ligand trimer
US-11267903-B2 · Mar 8, 2022 · US
Antigen binding molecules comprising a TNF family ligand trimer and a Tenascin binding moiety
US-11149083-B2 · Oct 19, 2021 · US
Bispecific antibodies specific for PD1 and TIM3
US-11130810-B2 · Sep 28, 2021 · US
Combination therapy with targeted 4-1bb (cd137) agonists
US-2020325225-A1 · Oct 15, 2020 · US
Antigen binding molecules comprising a trimeric tnf family ligand
US-2020270321-A1 · Aug 27, 2020 · US
Antigen binding molecules comprising a tnf family ligand trimer
US-2020247904-A1 · Aug 6, 2020 · US
Bispecific antibodies specific for ox40
US-2020071411-A1 · Mar 5, 2020 · US
Bispecific antibodies specific for OX40
US-10526413-B2 · Jan 7, 2020 · US
Anti-pd1 antibodies and methods of use
US-2019382489-A1 · Dec 19, 2019 · US
Antigen binding molecules comprising a tnf family ligand trimer
US-2019382507-A1 · Dec 19, 2019 · US
Tumor necrosis factor (TNF) family ligand trimer-containing antigen binding molecules
US-10464981-B2 · Nov 5, 2019 · US
Bispecific antibodies specific for pd1 and tim3
US-2019322748-A1 · Oct 24, 2019 · US
Tumor necrosis factor (TNF) family ligand trimer-containing antigen-binding molecules
US-10392445-B2 · Aug 27, 2019 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Hoffmann La Roche | 40 |
| Hofmann La Roche Inc | 1 |
| Hoffmann—La Roche Inc | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 40 |
| C07K2317/55 | 38 |
| A61K2039/505 | 31 |
| C07K2317/92 | 30 |
| C07K16/40 | 25 |